title: Immunogenicity of therapeutic proteins: influence of aggregation.
abstract: The elicitation of anti-drug antibodies (ADA) against biotherapeutics can have detrimental effects on drug safety, efficacy, and pharmacokinetics. The immunogenicity of biotherapeutics is, therefore, an important issue. There is evidence that protein aggregation can result in enhanced immunogenicity; however, the precise immunological and biochemical mechanisms responsible are poorly defined. In the context of biotherapeutic drug development and safety assessment, understanding the mechanisms underlying aggregate immunogenicity is of considerable interest. This review provides an overview of the phenomenon of protein aggregation, the production of unwanted aggregates during bioprocessing, and how the immune response to aggregated protein differs from that provoked by non-aggregated protein. Of particular interest is the nature of the interaction of aggregates with the immune system and how subsequent ADA responses are induced. Pathways considered here include 'classical' activation of the immune system involving antigen presenting cells and, alternatively, the breakdown of B-cell tolerance. Additionally, methods available to screen for aggregation and immunogenicity will be described. With an increased understanding of aggregation-enhanced immune responses, it may be possible to develop improved manufacturing and screening processes to avoid, or at least reduce, the problems associated with ADA.
authors.affiliation: Faculty of Life Sciences, University of Manchester , Manchester , UK.
authors.forename: Kirsty D
authors.initials: KD
authors.lastname: Ratanji
authors.forename: Jeremy P
authors.initials: JP
authors.lastname: Derrick
authors.forename: Rebecca J
authors.initials: RJ
authors.lastname: Dearman
authors.forename: Ian
authors.initials: I
authors.lastname: Kimber
mesh_terms: D000818:Animals; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D016899:Interferon-beta / Q000276:immunology; D066263:Protein Aggregation, Pathological; D015202:Protein Engineering; D017510:Protein Folding; D011506:Proteins / Q000737:chemistry / Q000276:immunology* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000276:immunology
chemical_list: D011506:Proteins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; D016899:Interferon-beta
references.citation: Biochem Biophys Res Commun. 1996 Sep 13;226(2):378-84
references.pmid: 8806643
references.citation: J Interferon Cytokine Res. 1997 Jul;17 Suppl 1:S29-33
references.pmid: 9241613
references.citation: N Engl J Med. 2002 Feb 14;346(7):469-75
references.pmid: 11844847
references.citation: AAPS PharmSci. 2003;5(2):E10
references.pmid: 12866937
references.citation: Perit Dial Int. 2007 Jun;27 Suppl 2:S303-7
references.pmid: 17556324
references.citation: MAbs. 2010 May-Jun;2(3):256-65
references.pmid: 20400861
references.citation: Biomaterials. 2010 Nov;31(32):8475-83
references.pmid: 20708258
references.citation: J Pharm Sci. 2008 Oct;97(10):4347-66
references.pmid: 18240293
references.citation: J Pharm Sci. 2009 Apr;98(4):1246-77
references.pmid: 18683878
references.citation: Trends Biotechnol. 2007 Jun;25(6):254-61
references.pmid: 17433843
references.citation: J Infect Dis. 2003 Feb 1;187(3):495-9
references.pmid: 12552434
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2608-11
references.pmid: 10077557
references.citation: Expert Rev Clin Pharmacol. 2011 Sep;4(5):623-31
references.pmid: 22114889
references.citation: Pharm Res. 2011 Jul;28(7):1591-605
references.pmid: 21400018
references.citation: Nephrol Dial Transplant. 2005 May;20 Suppl 3:iii33-40
references.pmid: 15824129
references.citation: J Clin Endocrinol Metab. 1980 Oct;51(4):691-7
references.pmid: 7419661
references.citation: J Pharm Sci. 2005 Jun;94(6):1368-81
references.pmid: 15858848
references.citation: Science. 1983 Feb 11;219(4585):632-7
references.pmid: 6337396
references.citation: Autoimmun Rev. 2004 Nov;3(7-8):471-5
references.pmid: 15546793
references.citation: PDA J Pharm Sci Technol. 1995 Jul-Aug;49(4):160-5
references.pmid: 7552234
references.citation: J Clin Invest. 2005 Aug;115(8):2257-67
references.pmid: 16041408
references.citation: Virology. 2007 Jun 20;363(1):59-68
references.pmid: 17320136
references.citation: Pharm Res. 2011 Oct;28(10):2379-85
references.pmid: 21744171
references.citation: Kidney Int. 2005 Jun;67(6):2346-53
references.pmid: 15882278
references.citation: Allergy Asthma Clin Immunol. 2010 Dec 03;6(1):32
references.pmid: 21129189
references.citation: J Pharm Sci. 2010 Mar;99(3):1193-206
references.pmid: 19774651
references.citation: Biochemistry. 2002 May 21;41(20):6422-31
references.pmid: 12009905
references.citation: J Pharm Sci. 2006 Feb;95(2):358-71
references.pmid: 16372314
references.citation: Arch Biochem Biophys. 1998 Dec 1;360(1):121-34
references.pmid: 9826437
references.citation: Vox Sang. 1999;77 Suppl 1:90-9
references.pmid: 10529698
references.citation: Pharm Res. 2003 Sep;20(9):1325-36
references.pmid: 14567625
references.citation: Ann Neurol. 2000 Nov;48(5):706-12
references.pmid: 11079533
references.citation: Diabetes Care. 1993 Dec;16 Suppl 3:155-65
references.pmid: 8299472
references.citation: Clin Immunol. 2009 May;131(2):189-201
references.pmid: 19269256
references.citation: Discov Med. 2010 Jun;9(49):560-4
references.pmid: 20587346
references.citation: J Pharm Sci. 2009 Sep;98(9):3247-64
references.pmid: 19569057
references.citation: Annu Rev Immunol. 1997;15:235-70
references.pmid: 9143688
references.citation: Pharm Res. 2005 Jul;22(7):1186-94
references.pmid: 16028020
references.citation: J Pharm Sci. 1995 Jun;84(6):713-6
references.pmid: 7562409
references.citation: Clin Infect Dis. 2003 Mar 15;36(6):705-13
references.pmid: 12627354
references.citation: Clin Immunol. 2007 Jul;124(1):26-32
references.pmid: 17490912
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):11937-42
references.pmid: 19571001
references.citation: J Mol Biol. 2010 Aug 6;401(1):134-52
references.pmid: 20621668
references.citation: J Biol Chem. 2012 Jul 20;287(30):25266-79
references.pmid: 22584577
references.citation: J Allergy. 1969 Jan;43(1):45-54
references.pmid: 4178567
references.citation: J Mol Biol. 2012 Apr 6;417(4):309-35
references.pmid: 22306407
references.citation: J Am Chem Soc. 2006 Feb 8;128(5):1683-91
references.pmid: 16448142
references.citation: Biotechnol Bioeng. 1997 Jun 20;54(6):503-12
references.pmid: 18636406
references.citation: Ann Rheum Dis. 2010 Jan;69 Suppl 1:i72-76
references.pmid: 19995750
references.citation: Ann Rheum Dis. 2009 Nov;68(11):1739-45
references.pmid: 19019895
references.citation: Methods Mol Biol. 2011;716:267-80
references.pmid: 21318912
references.citation: J Pharm Sci. 2008 Aug;97(8):2924-35
references.pmid: 17973307
references.citation: Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9377-81
references.pmid: 1946348
references.citation: J Pharm Sci. 2009 Sep;98(9):3099-107
references.pmid: 18781611
references.citation: J Med Virol. 2004 Jan;72(1):138-42
references.pmid: 14635022
references.citation: Protein Eng. 1988 Sep;2(3):172-4
references.pmid: 3237680
references.citation: Pharm Res. 2011 Apr;28(4):920-33
references.pmid: 20972611
references.citation: Mol Immunol. 2008 May;45(10):2847-60
references.pmid: 18329101
references.citation: Curr Pharm Biotechnol. 2009 Jun;10(4):400-7
references.pmid: 19519415
references.citation: J Immunol. 2008 Aug 1;181(3):1767-79
references.pmid: 18641314
references.citation: J Pharm Sci. 2006 May;95(5):1084-96
references.pmid: 16552750
references.citation: Curr Med Res Opin. 2003;19(5):430-2
references.pmid: 13678480
references.citation: Pharm Res. 2011 Oct;28(10):2393-402
references.pmid: 21544687
references.citation: AAPS J. 2006 Aug 04;8(3):E501-7
references.pmid: 17025268
references.citation: Biochemistry. 2010 Nov 2;49(43):9328-38
references.pmid: 20843079
references.citation: Pharm Res. 2003 Dec;20(12):1903-7
references.pmid: 14725351
references.citation: Int J Pharm. 2012 Jul 15;431(1-2):1-11
references.pmid: 22546296
references.citation: Pharm Res. 2004 Jun;21(6):897-903
references.pmid: 15212151
references.citation: Nat Rev Drug Discov. 2005 Apr;4(4):298-306
references.pmid: 15803194
references.citation: MAbs. 2009 May-Jun;1(3):254-67
references.pmid: 20065649
references.citation: Neurology. 2002 Nov 26;59(10):1496-506
references.pmid: 12451188
references.citation: PLoS One. 2012;7(6):e36996
references.pmid: 22675476
references.citation: Fold Des. 1998;3(1):R9-23
references.pmid: 9502314
references.citation: Trends Pharmacol Sci. 2010 Feb;31(2):53-9
references.pmid: 19963283
references.citation: J Pharm Sci. 1998 Dec;87(12):1597-603
references.pmid: 10189273
references.citation: J Biol Chem. 2011 Jul 15;286(28):25118-33
references.pmid: 21454532
references.citation: Allergy Asthma Proc. 2007 May-Jun;28(3):313-9
references.pmid: 17619560
references.citation: J Pharm Sci. 2012 Feb;101(2):493-8
references.pmid: 21989781
references.citation: Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v9-12
references.pmid: 16959792
references.citation: Pharm Res. 2010 Sep;27(9):1812-24
references.pmid: 20499141
references.citation: Pharm Res. 2004 Feb;21(2):191-200
references.pmid: 15032301
references.citation: N Engl J Med. 2004 Sep 30;351(14):1403-8
references.pmid: 15459301
references.citation: Pharm Res. 2002 Apr;19(4):511-6
references.pmid: 12033388
references.citation: Science. 2000 Mar 31;287(5462):2501-3
references.pmid: 10741972
references.citation: Toxicol Pathol. 2013 Feb;41(2):280-302
references.pmid: 23471185
references.citation: J Biomed Mater Res. 1987 Sep;21(9):1125-33
references.pmid: 3667638
references.citation: J Pharm Sci. 2011 Feb;100(2):354-87
references.pmid: 20740683
references.citation: Biophys J. 2009 Jan;96(1):199-208
references.pmid: 19134476
references.citation: Nat Biotechnol. 2008 Aug;26(8):901-8
references.pmid: 18688246
references.citation: Trends Biotechnol. 2006 Jun;24(6):274-80
references.pmid: 16631266
references.citation: Bioinformatics. 2010 Feb 1;26(3):326-32
references.pmid: 20019059
references.citation: J Pharm Sci. 2009 Apr;98(4):1201-5
references.pmid: 18704929
references.citation: J Pharm Sci. 2009 Sep;98(9):3167-81
references.pmid: 19360857
references.citation: Nat Immunol. 2003 Apr;4(4):343-9
references.pmid: 12627229
references.citation: Rheumatology (Oxford). 2012 Apr;51(4):590-9
references.pmid: 22258390
references.citation: Transplantation. 2003 Aug 15;76(3):459-63
references.pmid: 12923429
references.citation: Blood. 2010 Jun 17;115(24):4976-8
references.pmid: 20558622
references.citation: Pharm Res. 1991 Mar;8(3):285-91
references.pmid: 2052513
references.citation: AAPS J. 2006 Sep 15;8(3):E572-9
references.pmid: 17025275
references.citation: Clin Infect Dis. 2001 Jan;32(1):76-102
references.pmid: 11118387
references.citation: Eur J Pharm Biopharm. 2005 Apr;59(3):407-17
references.pmid: 15760721
references.citation: J Nanobiotechnology. 2013 Apr 04;11:10
references.pmid: 23556511
references.citation: BMC Biochem. 2005 May 31;6:10
references.pmid: 15927061
references.citation: Curr Opin Immunol. 2002 Dec;14(6):744-59
references.pmid: 12413525
references.citation: AIDS Res Hum Retroviruses. 2006 Nov;22(11):1081-90
references.pmid: 17147493
references.citation: J Pharm Sci. 1990 Dec;79(12):1083-6
references.pmid: 2079655
references.citation: J Pharm Sci. 2012 Mar;101(3):914-35
references.pmid: 22161573
references.citation: Pharm Res. 2010 Apr;27(4):544-75
references.pmid: 20143256
references.citation: Autoimmune Dis. 2011;2011:939520
references.pmid: 22235365
references.citation: Science. 1993 Nov 26;262(5138):1448-51
references.pmid: 8248784
references.citation: Curr Opin Immunol. 1998 Aug;10(4):431-5
references.pmid: 9722919